207_Combined course Presentations
Positive prognostic role of MGMT methylation
• Median OS: 18.2 vs 12.2 months
Overall, MGMT promoter
methylated in 45% of patients
MGMT promoter was an independent favorable prognostic factor, irrespective of treatment.
Hegi M. et al. NEJM 2005;352
Made with FlippingBook